Niquitin (Nicotine)

Nicotine, the active ingredient in Niquitin, is a nicotinic receptor agonist presented as a transdermal patch for transdermal use. It helps adult smokers reduce nicotine withdrawal symptoms and supports smoking cessation by delivering a controlled dose of nicotine through the skin.

GNH USA supplies Niquitin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory documentation for importers. Our global logistics network ensures timely delivery across continents, with support for customs clearance and post‑sale service.

Niquitin is a nicotinic receptor agonist used in smoking cessation therapy. - Smoking cessation: assists adult smokers in quitting by delivering a steady dose of nicotine, which reduces withdrawal symptoms and cravings, facilitating a gradual reduction in tobacco use. - Nicotine dependence: helps manage cravings and physiological dependence in individuals attempting to stop tobacco use, providing a controlled nicotine supply that mimics the nicotine plasma profile of cigarettes. - Relapse prevention: supports maintenance of abstinence after initial quitting by stabilizing nicotine levels, thereby decreasing the likelihood of relapse during the critical early cessation period.

Niquitin may cause a range of adverse reactions, most of which are related to the transdermal delivery system. Common Side Effects: - Skin irritation: redness, itching, or mild rash at the patch site. - Local burning sensation: transient warmth or tingling. - Headache: mild to moderate. Serious or Rare Side Effects: - Severe allergic reaction: swelling, hives, or breathing difficulty. - Large skin blistering: extensive bullae formation. - Persistent hypotension: marked drop in blood pressure causing faintness.

When using Niquitin, several precautions should be observed to ensure safety and effectiveness. - Assess cardiovascular status: patients with heart disease should be evaluated before use. - Avoid use in children: nicotine patches are not indicated for individuals under 18 years. - Do not apply to damaged or irritated skin: ensure the skin is clean, dry, and intact. - Rotate application sites: change patch location each day to minimize skin irritation. - Monitor for nicotine toxicity: watch for signs such as nausea, vomiting, or rapid heart rate. - Store below 25°C: keep in the original packaging, protect from moisture and direct heat.

Niquitin can interact with other medicines; awareness of these interactions helps prevent adverse effects. Major Interactions (Avoid): - Other nicotine replacement products: concurrent use may cause nicotine overdose. - Monoamine oxidase inhibitors (MAOIs): combined use can increase the risk of hypertensive crisis. Moderate Interactions (Monitor Closely): - Beta‑blockers: nicotine may enhance bradycardia or hypotension; monitor heart rate and blood pressure. - Insulin or oral hypoglycemics: nicotine can affect glucose control; monitor blood sugar levels. - Antidepressants (SSRIs): may increase the incidence of nausea when combined with nicotine.